These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37062358)

  • 1. Intravenous Immunoglobulin: Mechanism of Action in Autoimmune and Inflammatory Conditions.
    Bayry J; Ahmed EA; Toscano-Rivero D; Vonniessen N; Genest G; Cohen CG; Dembele M; Kaveri SV; Mazer BD
    J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1688-1697. PubMed ID: 37062358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
    Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
    Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.
    Bayry J; Misra N; Latry V; Prost F; Delignat S; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Clin Biol; 2003 Jun; 10(3):165-9. PubMed ID: 12798851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation by intravenous immunoglobulin: role of regulatory T cells.
    Maddur MS; Othy S; Hegde P; Vani J; Lacroix-Desmazes S; Bayry J; Kaveri SV
    J Clin Immunol; 2010 May; 30 Suppl 1():S4-8. PubMed ID: 20405183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients treated with high-dose intravenous immunoglobulin show selective activation of regulatory T cells.
    Tjon AS; Tha-In T; Metselaar HJ; van Gent R; van der Laan LJ; Groothuismink ZM; te Boekhorst PA; van Hagen PM; Kwekkeboom J
    Clin Exp Immunol; 2013 Aug; 173(2):259-67. PubMed ID: 23607448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases.
    Ruiz de Souza V; Kaveri SV; Kazatchkine MD
    Clin Exp Rheumatol; 1993; 11 Suppl 9():S33-6. PubMed ID: 8354005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous immunoglobulin therapy].
    Mouthon L
    Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin.
    Ahmed AR; Kaveri S
    Front Immunol; 2018; 9():1189. PubMed ID: 30072982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy.
    Kaveri SV; Maddur MS; Hegde P; Lacroix-Desmazes S; Bayry J
    Clin Exp Immunol; 2011 Jun; 164 Suppl 2(Suppl 2):2-5. PubMed ID: 21466545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Intravenous Immunoglobulins on Human Innate Immune Cells: Collegium Internationale Allergologicum Update 2024.
    Jandus C; Jandus P
    Int Arch Allergy Immunol; 2024; 185(10):975-996. PubMed ID: 38852585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic indications of intravenous immunoglobulins].
    Tellier Z; Mouthon L
    Transfus Clin Biol; 2003 Jun; 10(3):179-84. PubMed ID: 12798854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders.
    Ballow M
    J Allergy Clin Immunol; 2011 Feb; 127(2):315-23; quiz 324-5. PubMed ID: 21185071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunomodulatory effects of intravenous immunoglobulins].
    Kazatchkine M; Mouthon L; Kaveri SV
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S13-8. PubMed ID: 10896983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective.
    Sibéril S; Elluru S; Graff-Dubois S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV
    Ann N Y Acad Sci; 2007 Sep; 1110():497-506. PubMed ID: 17911465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IVIG-mediated effector functions in autoimmune and inflammatory diseases.
    Galeotti C; Kaveri SV; Bayry J
    Int Immunol; 2017 Dec; 29(11):491-498. PubMed ID: 28666326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of intravenous immunoglobulin G (IVIG).
    Looney RJ; Huggins J
    Best Pract Res Clin Haematol; 2006; 19(1):3-25. PubMed ID: 16377538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Immunoglobulin Therapy in Pediatric Disease: a Review of Immune Mechanisms.
    Wong PH; White KM
    Clin Rev Allergy Immunol; 2016 Dec; 51(3):303-314. PubMed ID: 26142065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations.
    Späth PJ; Schneider C; von Gunten S
    Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):215-231. PubMed ID: 27638480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intravenous immunoglobulin (IVIG) therapy in adults.
    Herrod HG
    Allergy Proc; 1994; 15(6):309-12. PubMed ID: 7721079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of immunomodulatory action of intravenous immunoglobulin in autoimmune and systemic inflammatory diseases.
    Vassilev T; Kazatchkine MD
    Ther Apher; 1997 Feb; 1(1):38-41. PubMed ID: 10225779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.